Analyst Price Target is $72.50
▲ +9.43% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for OrthoPediatrics in the last 3 months. The average price target is $72.50, with a high forecast of $80.00 and a low forecast of $57.00. The average price target represents a 9.43% upside from the last price of $66.25.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in OrthoPediatrics. This Buy consensus rating has held steady for over two years.
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.